Alzheimer’s Research Is On a Roll
There is some exciting news coming out of medical research lately, particularly as it pertains to Alzheimer’s disease. In early July, the Food and Drug Administration granted approval to the drug Leqembi, generically known as lecanemab, to target what it calls “the fundamental pathophysiology” of the disease. In layman’s terms, the treatment targets and affects […]
Alzheimer’s Research Is On a Roll Read More »